Ken Herrmann | IKIM MMLhttps://mml.kite.ume.de/authors/ken-herrmann/Ken HerrmannHugoBlox Kit (https://hugoblox.com)en-usFri, 01 May 2026 00:00:00 +0000https://mml.kite.ume.de/media/authors/ken-herrmann_hu_dbf61b5d38bbb2af.jpegKen Herrmannhttps://mml.kite.ume.de/authors/ken-herrmann/Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registryhttps://mml.kite.ume.de/publications/guberina-salvage-2026/Fri, 01 May 2026 00:00:00 +0000https://mml.kite.ume.de/publications/guberina-salvage-2026/Explainable AI Predicts Hematoxicity from Cancer Treatment Using Multimodal Real-World Datahttps://mml.kite.ume.de/publications/keyl-explainable-2026/Wed, 01 Apr 2026 00:00:00 +0000https://mml.kite.ume.de/publications/keyl-explainable-2026/Screening for patients at risk for cardiac amyloidosis via electronic health records: A multicenter machine learning development and validation studyhttps://mml.kite.ume.de/publications/spielvogel-screening-2026/Wed, 01 Apr 2026 00:00:00 +0000https://mml.kite.ume.de/publications/spielvogel-screening-2026/Region-Normalized DPO for Medical Image Segmentation under Noisy Judgeshttps://mml.kite.ume.de/publications/kalisch-region-normalized-2026/Thu, 01 Jan 2026 00:00:00 +0000https://mml.kite.ume.de/publications/kalisch-region-normalized-2026/AutoPET Challenge on Fully Automated Lesion Segmentation in Oncologic PET/CT Imaging, Part 2: Domain Generalizationhttps://mml.kite.ume.de/publications/dexl-autopet-2025/Mon, 01 Dec 2025 00:00:00 +0000https://mml.kite.ume.de/publications/dexl-autopet-2025/CT-GRAPH: Hierarchical Graph Attention Network for Anatomy-Guided CT Report Generationhttps://mml.kite.ume.de/publications/kalisch-ct-graph-2025/Wed, 01 Oct 2025 00:00:00 +0000https://mml.kite.ume.de/publications/kalisch-ct-graph-2025/Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratificationhttps://mml.kite.ume.de/publications/borys-leveraging-2025/Wed, 01 Oct 2025 00:00:00 +0000https://mml.kite.ume.de/publications/borys-leveraging-2025/Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligencehttps://mml.kite.ume.de/publications/keyl-decoding-2025/Sat, 01 Feb 2025 00:00:00 +0000https://mml.kite.ume.de/publications/keyl-decoding-2025/Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyhttps://mml.kite.ume.de/publications/karpinski-combining-2024/Sun, 01 Sep 2024 00:00:00 +0000https://mml.kite.ume.de/publications/karpinski-combining-2024/Establishing Medical Intelligence - Leveraging FHIR to Improve Clinical Management: a retrospective cohort and clinical implementation studyhttps://mml.kite.ume.de/publications/brehmer-establishing-2024/Thu, 01 Aug 2024 00:00:00 +0000https://mml.kite.ume.de/publications/brehmer-establishing-2024/Characteristics and outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting.https://mml.kite.ume.de/publications/kersting-characteristics-2024/Thu, 01 Feb 2024 00:00:00 +0000https://mml.kite.ume.de/publications/kersting-characteristics-2024/Anatomy-Guided Pathology Segmentationhttps://mml.kite.ume.de/publications/jaus-anatomy-guided-2024/Mon, 01 Jan 2024 00:00:00 +0000https://mml.kite.ume.de/publications/jaus-anatomy-guided-2024/Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligencehttps://mml.kite.ume.de/publications/keyl-decoding-2023/Sun, 01 Oct 2023 00:00:00 +0000https://mml.kite.ume.de/publications/keyl-decoding-2023/Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimenshttps://mml.kite.ume.de/publications/darr-intraoperative-2023/Tue, 01 Aug 2023 00:00:00 +0000https://mml.kite.ume.de/publications/darr-intraoperative-2023/Accurate Fine-Grained Segmentation of Human Anatomy in Radiographs via Volumetric Pseudo-Labelinghttps://mml.kite.ume.de/publications/seibold-accurate-2023/Thu, 01 Jun 2023 00:00:00 +0000https://mml.kite.ume.de/publications/seibold-accurate-2023/Establishing Medical Intelligence - Leveraging FHIR to Improve Clinical Managementhttps://mml.kite.ume.de/publications/brehmer-establishing-2023/Thu, 01 Jun 2023 00:00:00 +0000https://mml.kite.ume.de/publications/brehmer-establishing-2023/Evaluation of thresholding methods for the quantifcation of 68Ga‑PSMA‑11 PET molecular tumor volume and their efect on survival prediction in patients with advanced prostate cancer undergoing 177Lu‑PSMA‑617 radioligand therapyhttps://mml.kite.ume.de/publications/kim-evaluation-2023/Sun, 01 Jan 2023 00:00:00 +0000https://mml.kite.ume.de/publications/kim-evaluation-2023/Artificial intelligence guided enhancement of digital PET: scans as fast as CT?https://mml.kite.ume.de/publications/hosch-artificial-2022/Fri, 01 Jul 2022 00:00:00 +0000https://mml.kite.ume.de/publications/hosch-artificial-2022/Virtual Biopsy: Just an AI Software or a Medical Procedure?https://mml.kite.ume.de/publications/murray-virtual-2022/Tue, 01 Feb 2022 00:00:00 +0000https://mml.kite.ume.de/publications/murray-virtual-2022/Joint Imaging Platform for Federated Clinical Data Analyticshttps://mml.kite.ume.de/publications/scherer-joint-2020/Sun, 01 Nov 2020 00:00:00 +0000https://mml.kite.ume.de/publications/scherer-joint-2020/PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysishttps://mml.kite.ume.de/publications/seifert-psma-2020/Tue, 01 Sep 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-psma-2020/Semi-automatically quantified tumor volume using Ga-68-PSMA-11-PET as biomarker for survival in patients with advanced prostate cancerhttps://mml.kite.ume.de/publications/seifert-semi-automatically-2020/Wed, 01 Apr 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-semi-automatically-2020/Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving $^textrm177$ Lu-PSMA-617 Radioligand Therapyhttps://mml.kite.ume.de/publications/seifert-analysis-2020/Wed, 01 Jan 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-analysis-2020/